Identifying depression in the first postpartum year: guidelines for office-based screening and referral

Area of Science:

• Psychiatry
• Obstetrics & Gynecology
• Clinical Psychology

Background:

• Postpartum-onset major depression (PPMD) affects 10-15% of women.
• Previous PPMD is a significant risk factor for recurrence.
• Early and accurate screening is crucial for timely intervention.

Purpose of the Study:

• To evaluate the Edinburgh Postnatal Depression Scale (EPDS) as a prospective screening tool for major depression (MD) in women with a history of PPMD.
• To assess the relationship between EPDS scores and PPMD recurrence.
• To provide clinical guidelines for EPDS use in primary care.

Main Methods:

• A double-blind, randomized clinical trial involving pregnant women with prior PPMD but no current depression.
• Participants received nortriptyline or placebo postpartum to prevent PPMD.
• The EPDS was administered weekly for 20 weeks and followed for 1 year, with depression recurrence confirmed by clinical interview.

Main Results:

• Of 50 women, 13 experienced MD recurrence within 20 weeks, and 20 within the first year.
• An EPDS score >9 at 4 weeks postpartum identified 60% of those with recurrence in the first 20 weeks.
• The EPDS identified 80% of women who recurred within the first postpartum year.

Conclusions:

• The EPDS is a validated and effective screening tool for major depression in women with a history of postpartum depression.
• The findings support the use of the EPDS in primary care settings for early identification of postpartum depression.
• Clinical guidelines are proposed for integrating EPDS screening into postpartum care for at-risk populations.